List of Cancer Research Technology Limited patents

Patents where

Current Assignee

Name

‌

Cancer Research Technology Limited

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7205311 Therapeutic acridone and acridine compounds	Patent 7205311 was granted and assigned to Cancer Research Technology Limited on April, 2007 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7205311	April 17, 2007
‌ US Patent 8058045 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use	Patent 8058045 was granted and assigned to Cancer Research Technology Limited on November, 2011 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	8058045	November 15, 2011
‌ US Patent 7300930 Therapeutic acridone and acridine compounds	Patent 7300930 was granted and assigned to Cancer Research Technology Limited on November, 2007 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7300930	November 27, 2007
‌ US Patent 8367658 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use	Patent 8367658 was granted and assigned to Cancer Research Technology Limited on February, 2013 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	8367658	February 5, 2013
‌ US Patent 7144893 4-aryl quinols and analogs thereof as therapeutic agents	Patent 7144893 was granted and assigned to Cancer Research Technology Limited on December, 2006 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7144893	December 5, 2006
‌ US Patent 8431596 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use	Patent 8431596 was granted and assigned to Cancer Research Technology Limited on April, 2013 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	8431596	April 30, 2013
‌ US Patent 7226918 DNA-PK inhibitors	Patent 7226918 was granted and assigned to Cancer Research Technology Limited on June, 2007 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7226918	June 5, 2007
‌ US Patent 9394301 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use	Patent 9394301 was granted and assigned to Cancer Research Technology Limited on July, 2016 by the United States Patent and Trademark Office.	‌ Cancer Research Technology Limited	‌ Cancer Research Technology Limited	United States Patent and Trademark Office	9394301	July 19, 2016
‌ US Patent 6916949 Methods of chemical systhesis of phenolic nitrogen mustard prodrugs	Patent 6916949 was granted and assigned to Cancer Research Technology Limited on July, 2005 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	6916949	July 12, 2005
‌ US Patent 7115619 N	Patent 7115619 was granted and assigned to Cancer Research Technology Limited on October, 2006 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7115619	October 3, 2006
‌ US Patent 10995073 PARG inhibitory compounds	Patent 10995073 was granted and assigned to Cancer Research Technology Limited on May, 2021 by the United States Patent and Trademark Office.	‌ Cancer Research Technology Limited	‌ Cancer Research Technology Limited	United States Patent and Trademark Office	10995073	May 4, 2021
‌ US Patent 10508086 PARG inhibitory compounds	Patent 10508086 was granted and assigned to Cancer Research Technology Limited on December, 2019 by the United States Patent and Trademark Office.	‌ Cancer Research Technology Limited	‌ Cancer Research Technology Limited	United States Patent and Trademark Office	10508086	December 17, 2019
‌ US Patent 7105518 Thiopyrane-4-ones as DNA protein kinase inhibitors	Patent 7105518 was granted and assigned to Cancer Research Technology Limited on September, 2006 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7105518	September 12, 2006
‌ US Patent 11447549 Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody			‌ Cancer Research Technology Limited	United States Patent and Trademark Office	11447549	September 20, 2022
‌ US Patent 10414726 Therapeutic agents	Patent 10414726 was granted and assigned to Cancer Research Technology Limited on September, 2019 by the United States Patent and Trademark Office.	‌ Cancer Research Technology Limited	‌ Cancer Research Technology Limited	United States Patent and Trademark Office	10414726	September 17, 2019
‌ US Patent 7563818 Photosensitizer functionalised nanoparticles	Patent 7563818 was granted and assigned to Cancer Research Technology Limited on July, 2009 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7563818	July 21, 2009
‌ US Patent 7312082 Crystal structure of G-quadruplex containing a potassium ion	Patent 7312082 was granted and assigned to Cancer Research Technology Limited on December, 2007 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7312082	December 25, 2007
‌ US Patent 7510830 Cancer treatment by combination therapy	Patent 7510830 was granted and assigned to Cancer Research Technology Limited on March, 2009 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7510830	March 31, 2009
‌ US Patent 11447505 Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer	Patent 11447505 was granted and assigned to Cancer Research Technology Limited on September, 2022 by the United States Patent and Trademark Office.	‌ Cancer Research Technology Limited	‌ Cancer Research Technology Limited	United States Patent and Trademark Office	11447505	September 20, 2022
‌ US Patent 7816334 Materials and methods relating to immune responses to fusion proteins	Patent 7816334 was granted and assigned to Cancer Research Technology Limited on October, 2010 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7816334	October 19, 2010
‌ US Patent 10533932 Apparatus and methods for liquid separation and capture of biologics	Patent 10533932 was granted and assigned to Cancer Research Technology Limited on January, 2020 by the United States Patent and Trademark Office.	‌ Cancer Research Technology Limited	‌ Cancer Research Technology Limited	United States Patent and Trademark Office	10533932	January 14, 2020
‌ US Patent 7585893 Anti-cancer composition comprising DMXAA or related compound	Patent 7585893 was granted and assigned to Cancer Research Technology Limited on September, 2009 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7585893	September 8, 2009
‌ US Patent 7410643 Materials and methods relating to fusion proteins for inducing an immune response	Patent 7410643 was granted and assigned to Cancer Research Technology Limited on August, 2008 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7410643	August 12, 2008
‌ US Patent 7462642 Anti-cancer combinations	Patent 7462642 was granted and assigned to Cancer Research Technology Limited on December, 2008 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7462642	December 9, 2008
‌ US Patent 7241618 Expression system	Patent 7241618 was granted and assigned to Cancer Research Technology Limited on July, 2007 by the United States Patent and Trademark Office.		‌ Cancer Research Technology Limited	United States Patent and Trademark Office	7241618	July 10, 2007

...

Results per page:

143 results

0 selected

143 results

0 selected